HBI-8000

· HUYABIO International, LLC

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for HBI-8000, covering 2016-02-01 to 2026-07-30. Get the full timeline:

Most recent: Clinical Trial Results: Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing